ALIOS BIOPHARMA, INC.
46Patents
43Active
46Granted
56Portfolio score
Filing activity: Feb 8, 2006 → Feb 26, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8871737B2 | Substituted nucleotide analogs | Emerging Cross-Sectional Technologies | 107 | Active |
| US8980865B2 | Substituted nucleotide analogs | Chemistry; Metallurgy | 76 | Active |
| US9249174B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 64 | Active |
| US9243022B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 55 | Active |
| US8772474B2 | Cyclic nucleotide analogs | Emerging Cross-Sectional Technologies | 55 | Active |
| US8877731B2 | Azido nucleosides and nucleotide analogs | Chemistry; Metallurgy | 54 | Active |
| US9278990B2 | Substituted nucleotide analogs | Emerging Cross-Sectional Technologies | 52 | Active |
| US9603864B2 | Substituted nucleosides, nucleotides and analogs thereof | Emerging Cross-Sectional Technologies | 50 | Active |
| US9605018B2 | Substituted nucleotide analogs | Chemistry; Metallurgy | 46 | Active |
| US9603863B2 | Substituted nucleosides, nucleotides and analogs thereof | Human Necessities | 41 | Active |
| US9815864B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 34 | Active |
| US9012427B2 | Pharmaceutical combinations comprising a thionucleotide analog | Human Necessities | 31 | Active |
| US8846896B2 | Methods of preparing substituted nucleotide analogs | Chemistry; Metallurgy | 29 | Active |
| US8895723B2 | Methods of preparing substituted nucleotide analogs | Chemistry; Metallurgy | 26 | Active |
| US9073960B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 25 | Active |
| US9890188B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 23 | Active |
| US10307439B2 | Substituted nucleosides, nucleotides and analogs thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US9598457B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 20 | Active |
| US9862743B2 | Substituted nucleosides, nucleotides and analogs thereof | Emerging Cross-Sectional Technologies | 20 | Active |
| US9758544B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 19 | Active |
| US10052342B2 | Substituted nucleosides, nucleotides and analogs thereof | Human Necessities | 18 | Active |
| US9441007B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 13 | Active |
| US10112966B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 13 | Active |
| US9365605B2 | Cyclic nucleotide analogs | Emerging Cross-Sectional Technologies | 12 | Active |
| US10144755B2 | Substituted nucleosides, nucleotides and analogs thereof | Chemistry; Metallurgy | 11 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.